Xspray Pharma AB s institutional investors lost 19 percent over the past week but have profited from longer-term gains - Simply Wall St
| XSPRAY Stock | SEK 42.40 0.45 1.07% |
About 51% of XSpray Pharma's investor base is interested to short. The analysis of current outlook of investing in XSpray Pharma AB suggests that many traders are impartial regarding XSpray Pharma's prospects. The current market sentiment, together with XSpray Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use XSpray Pharma AB stock news signals to limit their universe of possible portfolio assets.
XSpray |
Xspray Pharma AB s institutional investors lost 19 percent over the past week but have profited from longer-term gains Simply Wall St
Read at news.google.com
 |
XSpray Pharma Fundamental Analysis
We analyze XSpray Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of XSpray Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of XSpray Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
XSpray Pharma is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
XSpray Pharma AB Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with XSpray Pharma stock to make a market-neutral strategy. Peer analysis of XSpray Pharma could also be used in its relative valuation, which is a method of valuing XSpray Pharma by comparing valuation metrics with similar companies.
Peers
XSpray Pharma Related Equities
| ATORX | Alligator Bioscience | 3.85 | ||||
| BINV | BioInvent International | 0.91 | ||||
| MOB | Moberg Pharma | 0.94 | ||||
| ONCO | Oncopeptides | 1.31 |
Complementary Tools for XSpray Stock analysis
When running XSpray Pharma's price analysis, check to measure XSpray Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XSpray Pharma is operating at the current time. Most of XSpray Pharma's value examination focuses on studying past and present price action to predict the probability of XSpray Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XSpray Pharma's price. Additionally, you may evaluate how the addition of XSpray Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |